Marker Therapeutics Inc. (MRKR) Fundamentals

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.
SHARE INFORMATION
Market Cap$ 37,494,235
Shares Outstanding83,599,187
Float58,844,416
Percent Float70.39%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 1,241,710
Latest Fiscal EPS$ -0.56
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions131
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months1,602,133
Institutional Holdings Percent34.2%
Institutional Sold Previous 3 Months7,235,231
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months400,000
Insider Holdings Percent21.7
Insider Sold Previous 3 Months-
Insider Shares Owned18,181,622
TRADING INFO
52 Week High$ 2.05
52 Week Low$ 0.25
52 Week High Change$ -77.35
21 Day Moving Average$ 0.3745
21 Day Extended Moving Average$ 0.395609
50 Day Moving Average$ 0.3367
50 Day Extended Moving Average$ 0.365809
200 Day Moving Average$ 0.623255
200 Day Extended Moving Average$ 0.693975
10 Day Average Volume9,685,684
20 Day Average Volume4,924,514
30 Day Average Volume3,379,603
50 Day Average Volume2,149,182
Alpha-0.023176
Beta1.2674
Standard Deviation0.253793
R20.062389
7 Day Price Change$ 0.1185
7 Day Percent Change35.91%
21 Day Price Change$ 0.0985
21 Day Percent Change28.14%
30 Day Price Change$ 0.0962
30 Day Percent Change27.31%
Month to Date Price Change$ 0.1295
Month to Date Percent Change40.6%
Quarter to Date Price Change$ 0.1185
Quarter to Date Percent Change35.91%
180 Day Price Change$ -0.1115
180 Day Percent Change-19.91%
200 Day Price Change$ -0.1515
200 Day Percent Change-25.25%
Year to Date Price Change$ -0.5017
Year to Date Percent Change-52.8%

Marker Therapeutics Inc. (MRKR) Key Ratios

PROFITABILITY
EBIT Margin-3,261.0%
EBITDA Margin-2,999.8%
Pre-Tax Profit Margin-19,479.8%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 1,241,710
Revenue Per Share$ 0.0149
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.10
Total Debt To Equity0.30
Int Coverage0.00
Current Ratio3.80
Leverage Ratio1.50
Quick Ratio3.50
Long Term Debt To Capital0.24
VALUATION MEASURES
PE Ratio-0.90
Enterprise Value$ 23,870,652
Price to Sales30.1956
Price to Free Cash-1.40
PE High Last 5 Years-1.20
Price To Book1.10
Price To Cash Flow0.00
PE Low Last 5 Years-2.80
Price to Tangible Book1.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.70
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-62.16
Return on Equity-82.58
Return on Capital-65.12

Marker Therapeutics Inc. (MRKR) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMarcum LLP
CEOPeter L. Hoang
Emplyoees56
Last AuditUE
CIK0001094038
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address3200 Southwest Freeway
Suite2500
Houston, TX 77027
Websitehttp://www.markertherapeutics.com
Facsimile-
Telephone+1 713 400-6400
Emailinvestor.relations@markertherapeutics.com
Your Recent History
NASDAQ
MRKR
Marker The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220814 07:11:52